Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 4/20 | 0.60 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.60 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.60 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.60 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.60 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.60 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.60 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.52 |
| ▸ | HTR1B | P28222 | 9/20 | 0.86 |
| ▸ | HTR1D | P28221 | 6/20 | 0.86 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | HTR6 | P50406 | 11/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL7834732 | 1.00 | HTR1B (0.86) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| Fumaric Acid SCHEMBL7834727 | 1.00 | HTR1B (0.86) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL7103413 | 0.93 | HTR1B (1.00) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL7103416 | 0.93 | HTR1B (1.00) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL29391208 | 0.93 | HTR1B (1.00) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL8790026 | 0.90 | HTR1B (0.94) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL8790021 | 0.90 | HTR1B (0.94) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| Fumaric Acid SCHEMBL27391450 | 0.87 | HTR1B (0.64) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL8789303 | 0.84 | HTR1B (0.83) | HTR1BHTR1DHTR1ACHRM2ADRA2A | |
| SCHEMBL8789309 | 0.84 | HTR1B (0.83) | HTR1BHTR1DHTR1ACHRM2ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0785781-B1 | USE OF INDOLE DERIVATIVES FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS PERIPHERAL NEUROPATHIED, ARTHRITIS, ALLERGIC OR CHRONIC OBSTRUCTIVE AIRWAYS DISEASE, GLAUCOMA AND OCULAR INFLAMMATION | PFIZER LTD (GB) | 2001-12-19 | — | — | EP | disclosed |
| US-5994387-A | MIGRAINE THERAPY | PFIZER INC. (US) | 1999-11-30 | — | — | US | disclosed |
| US-5607951-A | SEROTONIN AGONIST FOR NERVOUS SYSTEM DISORDERS, ANALGESICS AND PSYCHOTHERAPEUTICS | PFIZER INC (US) | 1997-03-04 | — | — | US | disclosed |
| US-5578612-A | Indole derivatives | PFIZER INC. (US) | 1996-11-26 | — | — | US | disclosed |
| US-5559129-A | SEROTONIN (5HT1) ANTAGONIST FOR TREATMENT OF DEPRESSION, ANXIETY, EATING DISORDERS, OBESITY, DRUG ABUSE, HEADACHES, AND PAIN | PFIZER INC (US) | 1996-09-24 | — | — | US | disclosed |
| US-5559246-A | PROCESS OF DEHYDROHALOGENATION FOR CYCLIZATION TO PRODUCE PSYCHOTHERAPEUTIC AGENTS AND ANTISEROTONIN ANTAGONIST | PFIZER INC. (US) | 1996-09-24 | — | — | US | disclosed |
| US-5545644-A | SEROTONIN AGONISTS; HYPOTENSIVE AND ANXIOLYTIC AGENTS; ANALGESICS; ANTIDEPRESSANTS; EATING DISORDERS; DRUG ABUSE; HEADACHES; VASCULAR DISORDERS | PFIZER INC. (US) | 1996-08-13 | — | — | US | disclosed |